Log In
BCIQ
Print this Print this
 

Pollinex Quattro Japanese Cedar

  Manage Alerts
Collapse Summary General Information
Company Allergy Therapeutics plc
DescriptionSubcutaneous Japanese cedar allergy vaccine formulated with allergoids, tyrosine plus the toll-like receptor 4 (TLR4) agonist monophosphoryl lipid A (MPL)
Molecular Target Toll-like receptor 4 (TLR4)
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAllergy
Indication DetailsTreat Japanese cedar allergy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today